US English UK English Polish Italian Hungarian Greek Spanish German Australian English


   
in the news

understanding
your tests

inside the lab

about this site

site map

send us your
comments


home
 


ASMA

Also known as: Smooth Muscle Antibody (SMA), F-Actin Antibody
Formal name: Anti-Smooth Muscle Antibody and Anti-Actin Antibody
Related tests: Antinuclear antibody (ANA), Autoantibodies, Aspartate aminotransferase (AST), Bilirubin, Antimitochondrial antibody (AMA)
The Test
 
How is it used?
When is it ordered?
What does the test result mean?
Is there anything else I should know?

How is it used?
The ASMA test is primarily ordered along with antinuclear antibodies (ANA) to help diagnose autoimmune hepatitis. Other autoantibodies, such as liver-kidney microsomal type 1 (LKM1) antibodies and antimitochondrial antibodies (AMA), may also be ordered to help diagnose autoimmune hepatitis and distinguish it from other causes of liver disease or injury.

The anti-actin test may be ordered as an initial screening test for autoimmune hepatitis instead of the ASMA test. If it is positive, it may be followed by the ASMA to confirm the finding.




When is it ordered?
This test and the ANA test are ordered when a doctor suspects that the patient has autoimmune hepatitis. They are usually ordered when a patient presents with symptoms such as fatigue and jaundice (yellowing of the skin and eyes) along with abnormal findings on liver tests (such as aspartate aminotransferase (AST) and/or bilirubin), results that may be found during routine blood tests.

ASMA and ANA are usually ordered following or sometimes with a variety of tests that are used to help diagnose and/or rule out other causes of liver injury. These causes can include infections (such as viral hepatitis), drugs, alcohol abuse, toxins, genetic conditions, metabolic conditions, and primary biliary cirrhosis.

An anti-actin test may be ordered instead of the ASMA when the doctor wants to screen for autoimmune hepatitis. This test is relatively new. In some cases, it is taking the place of the ASMA test; in others it may be followed by an ASMA for confirmation. The ultimate clinical utility of the anti-actin test has yet to be established.




What does the test result mean?
NOTE: A standard reference range is not available for this test. Because reference values are dependent on many factors, including patient age, gender, sample population, and test method, numeric test results have different meanings in different labs. Your lab report should include the specific reference range for your test. Lab Tests Online strongly recommends that you discuss your test results with your doctor. For more information on reference ranges, please read Reference Ranges and What They Mean.

When significant amounts of ASMA and ANA are present in the blood, the most likely cause is autoimmune hepatitis. When both are present, then systemic lupus erythematosus can be essentially ruled out (ANA will be positive with lupus, but ASMA will not).

When anti-actin antibodies are present in significant quantities in a patient with clinical signs of autoimmune hepatitis, then it is likely that the patient has the condition. In most cases, if the anti-actin is positive, the ASMA will also be positive. Since actin is only one of several cytoskeleton proteins, it is possible for a person to have anti-smooth muscle antibodies even when the anti-actin test is negative.



Is there anything else I should know?
Concentrations of ASMA may be lower in children and in those with compromised immune systems, and levels may vary over the course of the disease. Up to 20% of patients with autoimmune hepatitis will not be positive for ASMA, ANA, or LKM1 antibodies.

Small amounts of ASMA may be present, along with AMA, in up to 50% of patients with primary biliary cirrhosis and may be found in other conditions such as infectious mononucleosis and some cancers. Anti-actin antibodies may be present in about 22% of patients with primary biliary cirrhosis

The presence of ASMA, anti-actin antibodies, and ANA are highly suggestive of autoimmune hepatitis but not diagnostic. When significant concentrations of both are present and the doctor suspects autoimmune hepatitis, then a liver biopsy may be performed to look for characteristic signs of damage and scarring in the liver tissue.






This article was last reviewed on December 21, 2005.
 
In the NewsUnderstanding Your TestsInside the Lab
About the SiteSite MapSend Us Your CommentsHome


We comply with the HONcode standard for trustworthy health
information:
verify here.


©2001-2008 American Association for Clinical Chemistry
Email concerns to

Terms of UsePrivacy